Kestra Medical Technologies (KMTS) Operating Leases (2024 - 2026)

Kestra Medical Technologies (KMTS) has 3 years of Operating Leases data on file, last reported at $4.3 million in Q1 2026.

• Operating Leases for Q1 2026 came in at $4.3 million, up 49.41% year-over-year; the trailing twelve-month figure through Jan 2026 was $4.3 million (up 49.41% YoY), and the FY2025 annual result was $3.0 million, up 14.93% from the prior year.
• Operating Leases advanced to $4.3 million in Q1 2026 per KMTS's latest filing, from $2.9 million in the prior quarter.
• Over five years, Operating Leases peaked at $4.3 million in Q1 2026 and troughed at $2.6 million in Q2 2024.
• A 3-year average of $3.1 million and a median of $2.9 million in 2025 frame the typical range for Operating Leases.
• The sharpest annual moves came in 2025 and 2026: Operating Leases grew 14.93% in 2025, then surged 49.41% in 2026.
• A 3-year view of Operating Leases shows it stood at $2.6 million in 2024, then rose by 9.15% to $2.9 million in 2025, then surged by 48.78% to $4.3 million in 2026.
• Business Quant data shows KMTS's Operating Leases at $4.3 million in Q1 2026, $2.9 million in Q4 2025, and $3.1 million in Q3 2025.